Asia Cannabis Corp. (“ACC” or the “Company”) (CSE:ASIA) announced the following corporate developments today:

ACC continues to successfully implement its business plan in SE Asia. In addition to its wide-ranging activities in the Kingdom of Cambodia, the Company is pleased to announce that it has entered a Memorandum of Understanding with the AmeriSeed Group (“AmeriSeed”). The purpose of this agreement is to allow ACC and AmeriSeed to collaborate in the pursuit and execution of a business development plan tied to the evaluation and implementation of seed and plant production techniques relating to hemp and other plants with medicinal, practical or other benefits. The parties are prepared to jointly provide managerial input, equipment, intellectual property and material to facilitate the operational needs of such a project in Thailand or wherever the parties determine is a viable venue for such an operation. As part of the execution of that business plan, ACC and AmeriSeed are prepared to either facilitate the creation of a company or otherwise establish a joint venture for the initial purpose of conducting evaluation and consultative work to determine the feasibility of completing such a project.


AmeriSeed engages in research and development activities as well as general operations in Chiang Mai, Thailand, and has expertise in the application of plant genetics, seed production and technology, plant production, sales and market dynamics. The company has an extensive record of successful operations in Thailand and elsewhere with worldwide sales of seed and plant products. The collaboration of ACC and AmeriSeed will give the companies access to senior level engineering and technical teams to foster project development and provide access to significant and unique technical and associated scientific data, equipment and infrastructure. Managements of both parties are confident that this collaboration will result in an increase in options in the greater region relative to expansion of the hemp-based food, fibre, fuel and foundation initiatives.

In commenting on this development, David Pinkman, CEO of ACC, stated: “We are very excited and pleased to have found a new partner in AmeriSeed. Both companies hold similar aspirations for the development of a progressive and positive hemp industry in the Southeast Asian region, and the technical and practical abilities of their respective teams are not only complementary, but also provide the solid foundation to create state-of-the-art and market leading hemp research and development programs. We look forward to a long and fruitful business relationship with this group.”

The Company also announced today its intention to complete a non-brokered private placement (the “Offering”) to sell a total of 17,500,000 common share units (the “Units”) of the Company to various investors at a price of $0.10 per Unit for gross proceeds of $1,750,000.00. Each Unit will consist of one common share of the Company (a “Common Share”) and one common share purchase warrant (a “Warrant”) with each warrant entitling the holder thereof to acquire one additional Common Share at a price of $0.25 per Common Share for a period of 12 months after the date of closing of the Offering. No finder’s fees will be payable as a consequence of closing this transaction, and securities issued pursuant to the Offering will be subject to a four month hold period. The offering is scheduled to close as soon as possible and remains subject to regulatory approval. Proceeds will be applied to the Company’s working capital.

About ACC:

ACC is an early stage international Agri-technology company which is in the process of creating a business focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities under the terms of a license agreement with InPlanta Biotechnologies Inc (“InPlanta”).

In conjunction with InPlanta, the Company plans to develop varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories With the data and associated knowledge gained from these activities, the Company intends to leverage the technology to develop a portfolio of strategic hemp investments to take advantage of both the changing social climate relative to hemp use and the historic acceptance of the use of these products and their derivatives in certain of the jurisdictions granted under the License Agreement.

For further information, contact:

David Pinkman
Chief Executive Officer
(403) 612-5655

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE

CANBUD Distribution Corp. (CSE:CBDX, FSE:CD0) leverages on timely and methodical execution of its revenue generating plan. It operates a trinitarian enterprise model in the plant-based protein, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) spaces. (www.canbudcorp.com).

Keep reading... Show less

(TheNewswire)

Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less

Further to its press release dated April 12, 2021, Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that it has oversubscribed and upsized its non-brokered private placement (the “Offering”) due to strong investor demand. The Company now anticipates that the Offering will be completed for gross proceeds of not less than $550,000.00, consisting of not less than 2,910,053 units (“Units”) at a price of $0.189 per Unit. Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire one Common Share at an exercise price of C$0.38 per Common Share for a period of 36 months from the date of closing of the Offering (the “Closing Date”), scheduled for April 22, 2021. The Units will have a hold period of four months and one day from the date of issuance.

Ayurcann CEO Igal Sudman commented: “We are very pleased with the demand we are seeing for the Offering. The feedback we have received to date is showing that our business is resonating with investors. We’re looking forward to closing the offering and proceeding with the planned Phase 2 build out, which will help greatly increase our facility’s capacity.”

Keep reading... Show less

UK InstaCoin APP Promises to Open NFTs up to the Masses through Social Media

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to provide an update on its recent investment in InstaCoin Technologies Ltd., a newly formed UK entity

Keep reading... Show less